In studies by other groups, CX3CR1 expression was investigated in different types of B cell lymphomas by reverse transcriptase-polymerase chain reaction (RT-PCR), immunohistochemistry, and flow cytometry. This evidence concerns the gene CX3CR1 and B-cell non-Hodgkin lymphoma.